Insulin Resistance and the IGF-I-Cortical Bone Relationship in Children Ages 9 to 13 Years
Joseph M Kindler1, Norman K Pollock2, Emma M Laing1
1Department of Foods and Nutrition, The University of Georgia, Athens, GA, USA.
Insights
Insulin resistance may hinder insulin-like growth factor-I (IGF-I)
Area of Science:
- Pediatric Endocrinology
- Skeletal Biology
- Metabolic Health
Background:
- Insulin-like growth factor-I (IGF-I) is crucial for pediatric bone and lean mass development.
- The impact of insulin resistance on IGF-I's role in cortical bone accrual in children is not well understood.
- Previous research suggests insulin resistance may affect IGF-I's influence on total body lean and bone mass.
Purpose of the Study:
- To investigate how insulin resistance affects the relationship between IGF-I and cortical bone geometry in children.
- To examine if lean mass mediates the association between IGF-I and cortical bone, and if this is influenced by insulin resistance.
Main Methods:
- Cross-sectional study of early adolescent boys and girls (ages 9-13) categorized by high or normal insulin resistance (HOMA-IR).
- Peripheral quantitative computed tomography (pQCT) measured tibial cortical bone; dual-energy X-ray absorptiometry (DXA) measured fat-free soft tissue mass (FFST).
- Fasting sera analyzed for IGF-I, insulin, and glucose; HOMA-IR calculated.
Main Results:
- Children with high HOMA-IR exhibited greater unadjusted IGF-I levels.
- Insulin resistance (HOMA-IR) negatively predicted cortical bone area (Ct.Ar) and strength (pSSI).
- IGF-I positively predicted bone outcomes, but this relationship was moderated by HOMA-IR; FFST mediated the IGF-I-bone relationship, with a weaker indirect effect in high HOMA-IR children.
Conclusions:
- Insulin resistance may suppress the beneficial effects of IGF-I on cortical bone development in children.
- The lean mass-dependent pathway linking IGF-I to cortical bone accrual is attenuated in the presence of high insulin resistance.
- Further prospective studies are warranted to confirm these findings and elucidate mechanisms.
Abstract:
IGF-I is a pivotal hormone in pediatric musculoskeletal development. Although recent data suggest that the role of IGF-I in total body lean mass and total body bone mass accrual may be compromised in children with insulin resistance, cortical bone geometric outcomes have not been studied in this context. Therefore, we explored the influence of insulin resistance on the relationship between IGF-I and cortical bone in children. A secondary aim was to examine the influence of insulin resistance on the lean mass-dependent relationship between IGF-I and cortical bone. Children were otherwise healthy, early adolescent black and white boys and girls (ages 9 to 13 years) and were classified as having high (n = 147) or normal (n = 168) insulin resistance based on the homeostasis model assessment of insulin resistance (HOMA-IR). Cortical bone at the tibia diaphysis (66% site) and total body fat-free soft tissue mass (FFST) were measured by peripheral quantitative computed tomography (pQCT) and dual-energy X-ray absorptiometry (DXA), respectively. IGF-I, insulin, and glucose were measured in fasting sera and HOMA-IR was calculated. Children with high HOMA-IR had greater unadjusted IGF-I (p < 0.001). HOMA-IR was a negative predictor of cortical bone mineral content, cortical bone area (Ct.Ar), and polar strength strain index (pSSI; all p ≤ 0.01) after adjusting for race, sex, age, maturation, fat mass, and FFST. IGF-I was a positive predictor of most musculoskeletal endpoints (all p < 0.05) after adjusting for race, sex, age, and maturation. However, these relationships were moderated by HOMA-IR (pInteraction < 0.05). FFST positively correlated with most cortical bone outcomes (all p < 0.05). Path analyses demonstrated a positive relationship between IGF-I and Ct.Ar via FFST in the total cohort (βIndirect Effect = 0.321, p < 0.001). However, this relationship was moderated in the children with high (βIndirect Effect = 0.200, p < 0.001) versus normal (βIndirect Effect = 0.408, p < 0.001) HOMA-IR. These data implicate insulin resistance as a potential suppressor of IGF-I-dependent cortical bone development, though prospective studies are needed. © 2017 American Society for Bone and Mineral Research.
More Related Videos
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Insulin: The Receptor and Signaling Pathways
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...


